Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Fiscus

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
The Journal of Infectious Diseases|March 14, 1998
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 TeamS A Fiscus, M D Hughes, J L Lathey, et al.
The Journal of Infectious Diseases|October 7, 2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359R M Gulick, X J Hu, S A Fiscus, et al.
The Journal of Infectious Diseases|March 14, 1998
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 TeamJ L Lathey, M D Hughes, S A Fiscus, et al.
Journal of Virology|July 10, 1999
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variantsL H Ping, J A Nelson, I F Hoffman, et al.
AIDS (London, England)|April 10, 1999
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentrationI F Hoffman, C S Jere, T E Taylor, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
The Journal of Infectious Diseases|March 14, 1998
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 TeamS A Fiscus, M D Hughes, J L Lathey, et al.
The Journal of Infectious Diseases|October 7, 2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359R M Gulick, X J Hu, S A Fiscus, et al.
The Journal of Infectious Diseases|March 14, 1998
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 TeamJ L Lathey, M D Hughes, S A Fiscus, et al.
Journal of Virology|July 10, 1999
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variantsL H Ping, J A Nelson, I F Hoffman, et al.
AIDS (London, England)|April 10, 1999
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentrationI F Hoffman, C S Jere, T E Taylor, et al.
Pageof 8